NASDAQ$BKYI
Bio-key International Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
BIO-key reported increased revenue and reduced net loss due to growth in Cloud ID-as-a-Service (IDaaS).
BIO-key International, Inc. reported a significant increase in revenue and a reduced net loss for the second quarter of 2021. The company's revenue grew by 223% compared to the same period last year, driven by increased license fee revenue and the acquisition of PortalGuard. The net loss available to common stockholders was reduced to $1.2 million, or ($0.15) per share, compared to a net loss of $1.6 million, or ($0.60) per share, in Q2 2020.
- Q2 revenue increased by 223% to $992k, driven by a $639k increase in license fee revenue.
- Gross profit increased to $753k with gross margin at 76% compared to 52% in Q2 2020.
- Net loss available to common stockholders was reduced to $1.2M, or ($0.15) per share.
- Company remains on track to achieve full-year revenue guidance of $8M to $12M.
Headline financials
Revenue & EPS history
Bio-key · Revenue · Quarterly
$992K
Revenue by segment
Bio-key · $924K total across 2 segments · Q2 2021
- License Fees$662K—71.6%
- Hardware$262K—28.4%
Forward guidance
BIO-key remains on track to achieve its full-year revenue guidance of $8M to $12M, representing approximately 250% growth over FY 2020. The company believes it can potentially achieve profitability within this guidance range, dependent on the timing of customer order activity and the mix of hardware and software revenues.
Tailwinds
- Top line revenues growing 223% in Q2’21 and 247% in the first six months of 2021
- Strong balance sheet
- Growing portfolio of solutions
- Increasing demand for IDaaS Cloud solutions
- Potential to achieve profitability dependent on customer order activity
Headwinds
- Revenue and profitability goals are dependent on the timing of significant customer order activity
- Goals are also dependent on the mix of hardware and software revenues.
- Experienced recent delays due to the impact of the COVID-19 pandemic.
- Impact of the COVID-19 pandemic on business operations, sales cycles, and personnel
- Delays in the development of products
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2021
-3.5%
Avg return
Earnings day
-5.3%
Avg return
5 days after
-8.9%
Avg return
30 days after
25%
16 / 63 earnings
Positive
+15.9%
Q1 2017
Best reaction
-25.9%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.7% | — | — | |
| Q3 2025 | -2.2% | -4.1% | -27.8% | |
| Q1 2025 | -6.0% | -2.5% | -2.5% | |
| Q2 2025 | -1.3% | -3.7% | -4.9% | |
| Q4 2024 | -23.6% | +2.4% | -6.0% | |
| Q3 2024 | -8.7% | -16.5% | -5.8% | |
| Q2 2024 | -12.0% | -12.0% | +8.5% | |
| Q1 2024 | -11.8% | -10.0% | +5.9% | |
| Q4 2025 | -4.1% | -9.5% | -15.0% | |
| Q4 2023 | -4.8% | -13.8% | -19.0% | |
| Q3 2023 | -10.6% | -15.8% | -10.5% | |
| Q2 2023 | -10.0% | -10.0% | -27.1% | |
| Q1 2023 | +5.3% | +21.5% | +13.8% | |
| Q4 2022 | -3.0% | +8.2% | -9.6% | |
| Q3 2022 | -17.4% | -27.1% | -45.1% | |
| Q2 2022 | -17.0% | -22.6% | -27.6% | |
| Q1 2022 | -2.0% | -6.0% | -17.9% | |
| Q4 2021 | -3.2% | -6.0% | -14.0% | |
| Q3 2021 | -8.2% | -10.8% | -27.5% | |
| Q2 2021 | -7.4% | -5.5% | +3.5% | |
| Q1 2021 | +6.1% | +8.4% | +32.3% | |
| Q4 2020 | +2.9% | -0.9% | -2.6% | |
| Q3 2020 | -8.7% | -4.4% | -3.3% | |
| Q2 2020 | +1.1% | -1.4% | -36.5% | |
| Q4 2019 | -24.2% | -20.7% | -9.8% | |
| Q3 2019 | -9.2% | -12.1% | +0.0% | |
| Q2 2019 | +1.8% | -6.8% | -29.5% | |
| Q1 2019 | -6.2% | -16.9% | -13.1% | |
| Q4 2018 | -6.8% | -4.8% | -9.5% | |
| Q3 2018 | +11.1% | +9.3% | +13.9% | |
| Q2 2018 | -2.2% | -2.2% | -10.4% | |
| Q1 2018 | -11.0% | -1.3% | -0.9% | |
| Q4 2017 | -6.5% | +2.0% | +7.6% | |
| Q3 2017 | -10.8% | -6.1% | -29.1% | |
| Q2 2017 | -3.1% | -4.3% | -10.6% | |
| Q1 2017 | +15.9% | +22.0% | +17.5% | |
| Q4 2016 | -7.8% | -5.1% | -14.1% | |
| Q3 2016 | -25.9% | -7.4% | -18.5% | |
| Q2 2016 | +0.0% | -4.2% | +8.3% | |
| Q1 2016 | -5.9% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | +0.0% | — | — | |
| Q2 2015 | +5.6% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | +0.0% | — | — | |
| Q1 2014 | -3.7% | — | — | |
| Q4 2013 | +7.7% | — | — | |
| Q3 2013 | -10.5% | — | — | |
| Q2 2013 | +3.0% | — | — | |
| Q1 2013 | +9.1% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | +14.3% | — | — | |
| Q1 2012 | +14.3% | — | — | |
| Q4 2011 | -9.1% | — | — | |
| Q3 2010 | -15.4% | — | — | |
| Q3 2011 | -15.4% | — | — | |
| Q2 2010 | +9.1% | — | — | |
| Q2 2011 | +9.1% | — | — | |
| Q1 2011 | -6.7% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q1 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro